United States
Kane Biotech has signed an exclusive distribution agreement with ProgenaCare Global LLC for revyve™ Antimicrobial Wound Gel in the United States wound care market.
Kane Biotech has signed an exclusive distribution agreement with ProgenaCare Global LLC for revyve™ Antimicrobial Wound Gel in the United States wound care market.
ProgenaCare is a purpose-driven medical device company leveraging cutting-edge advances in biomaterials and medical device technologies to provide effective, affordable advanced wound care solutions to patients across the socioeconomic spectrum and around the world.
Ordering contact information:
ProgenaCare Global, LLC
2275 Northwest Parkway SE
Suite 170
Marietta, GA 30067-9317
Phone: (877) 776-4362 Ext. 3
Email: customerservice@progenacare.com
Website: www.progenacare.com
Kane Biotech has established a distribution agreement with Salud Pharma S.A. for its revyve™ Antimicrobial Wound Gel. Through its distribution partners, Salud Pharma will register and commercialize revyve™ Antimicrobial Wound Gel throughout Colombia, Panama, and Costa Rica via wound care centers and pharmacies.
Salud Pharma S.A. is a pharmaceutical company that offers its customers high quality standards products through solid strategic partnerships in North and Latin America, where it has specialized and reliable distributors.
Ordering contact information:
TBA